Blog
SGLT2 Inhibitors Market to reach $29.73 Bn by 2032 as Diabetes and Cardiorenal Disorders Accelerate Demand
Strong Uptake of Advanced Therapies Elevates Global SGLT2 Inhibitors Expansion Through 2032 The SGLT2 inhibitors market continues its robust ascent, with the global valuation reaching
SNS Insider
December 2, 2025